research use only

Niraparib (MK-4827) PARP inhibitor

Cat.No.S2741

Niraparib (MK-4827) is a selective inhibitor of PARP1/2 with IC50 of 3.8 nM/2.1 nM, with great activity in cancer cells with mutant BRCA-1 and BRCA-2. It is >330-fold selective against PARP3, V-PARP and Tank1. This compound can form PARP–DNA complexes resulting in DNA damage, apoptosis, and cell death. Phase 3.
Jump to

Quality Control

Batch: Purity: 99.99%
99.99

Solubility in DMSO or Water

In vitro
Batch:

DMSO : 64 mg/mL (199.75 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Ethanol : 64 mg/mL

Water : Insoluble

The solubility data above are all experimental results (not literature values).

Molarity Calculator

Mass Concentration Volume Molecular Weight
Dilution Calculator Molecular Weight Calculator

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Read more about Niraparib (MK-4827) solubility in DMSO or water

Working Concentrations for Cell Culture Treatment

Step 1: Select a research area to find working concentrations, or search directly for a cell line

Read more about Niraparib (MK-4827) working concentrations for cell culture treatment

Working Concentrations for Animal Model Treatment

Step 1: Select a research area to find working concentrations, or search directly for an animal type

×

Mechanism of Action

Information Niraparib is a potent PARP1/2 inhibitor. It affects DDR signaling by trapping PARP at DNA breaks to inhibit tumor cell growth.

Read more about Niraparib (MK-4827) IC50 for cell-based and cell-free assays

Primary Applications and Mechanism of Action

Read more about Niraparib (MK-4827) Mechanism of Action

Chemical Information, Storage & Stability

Molecular Weight 320.39 Formula

C19H20N4O

Storage (From the date of receipt)
CAS No. 1038915-60-4 Download SDF Storage of Stock Solutions

Read more about storage & stability

Please select the combination compounds (Multiple selections allowed)
Please select a combination compound first

Read more comparative analysis about Niraparib (MK-4827)

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Frequently Asked Questions

Question 1:
How to reconstitute it for in vivo studies?

Answer:
It can be orally administered using the formulation 1% CMC-Na (suspension).